Home › Funds › Vanguard › Vanguard Advice Select International Growth Fund
Fund family: Vanguard · Filed by VANGUARD WHITEHALL FUNDS (CIK 1004655) · SEC series S000074280
Ticker: VAIGX (C000231925)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 443 with, 5 against, 2 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 1 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Vanguard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 97.8% | 324 | 94.5% | 1,082,514 |
| Backed environmental and social shareholder proposals at US companies | n/a | 3 | 0.9% | 6,718 |
Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Vanguard funds on 21 items (7.7% of the 272 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| NVIDIA CORPORATION | 2026-06-24 | Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2027. | Against | FOR — 33 of 36 Vanguard funds | Against | Approved, 94.8% support |
| KERING SA | 2026-05-28 | APPROVE COMPENSATION OF LUCA DE MEO, CEO FROM SEPTEMBER 15, 2025 TO DECEMBER 31, 2025 | For | AGAINST — 9 of 9 Vanguard funds | For | — |
| DELIVERY HERO SE | 2026-06-23 | ELECT ROGER RABALAIS TO THE SUPERVISORY BOARD | Against | FOR — 6 of 6 Vanguard funds | Against | — |
| DELIVERY HERO SE | 2026-06-23 | ELECT SCOTT FERGUSON TO THE SUPERVISORY BOARD | Against | FOR — 6 of 6 Vanguard funds | Against | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | APPROVE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES FOR PRIVATE PLACEMENTS UP TO AGGREGATE NOMINAL AMOUNT OF EUR 5 MILLION | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | APPROVE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES RESERVED FOR ONE OR MORE SPECIFICALLY DESIGNATED PERSONS UP TO AGGREGATE NOMINAL AMOUNT OF EUR 5 MILLION | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | APPROVE REMUNERATION POLICY OF CHAIRMAN AND CEO | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | APPROVE REMUNERATION POLICY OF VICE-CEO | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | AUTHORIZE BOARD TO INCREASE CAPITAL IN THE EVENT OF ADDITIONAL DEMAND RELATED TO DELEGATION SUBMITTED TO SHAREHOLDER VOTE UNDER ITEMS 15-18 | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | AUTHORIZE CAPITAL INCREASE OF UP TO 20 PERCENT OF ISSUED CAPITAL FOR CONTRIBUTIONS IN KIND | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| EXAIL TECHNOLOGIES SA | 2026-06-19 | AUTHORIZE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES WITHOUT PREEMPTIVE RIGHTS UP TO AGGREGATE NOMINAL AMOUNT OF EUR 5 MILLION | For | AGAINST — 5 of 5 Vanguard funds | For | — |
| KERING SA | 2026-05-28 | APPROVE REMUNERATION POLICY OF CHAIRMAN OF THE BOARD | For | AGAINST — 8 of 9 Vanguard funds | For | — |
| Novo Nordisk | 2025-11-14 | ELECT BRITT MEELBY JENSEN AS NEW DIRECTOR | For | ABSTAIN — 8 of 11 Vanguard funds | For | — |
| Novo Nordisk | 2025-11-14 | ELECT CEES DE JONG (VICE CHAIR) AS NEW DIRECTOR | For | ABSTAIN — 8 of 11 Vanguard funds | For | — |
| Novo Nordisk | 2025-11-14 | ELECT LARS REBIEN SORENSEN (CHAIR) AS NEW DIRECTOR | For | ABSTAIN — 8 of 11 Vanguard funds | For | — |
| Novo Nordisk | 2025-11-14 | ELECT MIKAEL DOLSTEN AS NEW DIRECTOR | For | ABSTAIN — 8 of 11 Vanguard funds | For | — |
| Novo Nordisk | 2025-11-14 | ELECT STEPHAN ENGELS AS NEW DIRECTOR | For | ABSTAIN — 8 of 11 Vanguard funds | For | — |
| ATLAS COPCO AB | 2026-04-28 | REELECT HANS STRABERG AS BOARD CHAIR | For | AGAINST — 7 of 10 Vanguard funds | For | — |
| ATLAS COPCO AB | 2026-04-28 | REELECT HANS STRABERG AS DIRECTOR | For | AGAINST — 7 of 10 Vanguard funds | For | — |
| ATLAS COPCO AB | 2026-04-28 | REELECT PETER WALLENBERG JR AS DIRECTOR | For | AGAINST — 7 of 10 Vanguard funds | For | — |
| COUPANG, INC. | 2026-06-11 | Election of Director: Director withdrawn | Abstain | FOR — 4 of 5 Vanguard funds | Against | — |
Download all 21 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 155 | 0 |
| Corporate Governance | 88 | 1 |
| Capital Structure | 75 | 0 |
| Audit-related | 36 | 0 |
| Other | 33 | 0 |
| Compensation | 32 | 0 |
| Say-on-Pay | 25 | 0 |
| Other Social Issues | 3 | 1 |
| Extraordinary Transactions | 2 | 0 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| MERCADOLIBRE, INC. | June 9, 2026 | $175M | 5 | 0 |
| MODERNA, INC. | May 6, 2026 | $149M | 5 | 0 |
| NVIDIA CORPORATION | June 24, 2026 | $103M | 16 | 4 |
| Moderna Inc | November 12, 2025 | $72M | 2 | 0 |
| COUPANG, INC. | June 11, 2026 | $46M | 10 | 0 |
| BIONTECH SE | May 15, 2026 | $29M | 14 | 0 |
| PDD Holdings Inc | December 19, 2025 | $22M | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| June 16, 2026 | SHOPIFY INC. | Shareholder Proposal Vote on the shareholder proposal, as disclosed in the Management Information Circular for the Meeting. Shareholder proposal | Against | For |
452 ballot items at 33 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Vanguard Advice Select International Growth Fund (VAIGX) voted at 33 shareholder meetings of 27 companies, on 452 ballot items in all. Where management made a recommendation, the fund followed it on 98.4% of the items and voted against it 5 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 5 shareholder proposals. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (97.8% against 94.5%). It voted differently from most Vanguard funds on 21 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.